Bruggeman, Arnout

Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial

Bruggeman, A., Vandendriessche, C., Hamerlinck, H., De Looze, D., Tate, D. J., Vuylsteke, M., De Commer, L., Devolder, L., Raes, J., Verhasselt, B., et al. (2024) · eClinicalMedicine

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 139

Gut microbiota regulates blood‐cerebrospinal fluid barrier function and Aβ pathology

Xie, J., Bruggeman, A., De Nolf, C., Vandendriessche, C., Van Imschoot, G., Van Wonterghem, E., Vereecke, L., & Vandenbroucke, R. E. (2023) · The EMBO Journal

Barrier Structure and Function StudiesGut microbiota and health

Cited by 125